GLP-1 medications are revolutionizing the way we treat type 2 diabetes and obesity. Additionally, researchers are exploring GLP-1s for everything from treating addiction and lowering... Details

Healthcare organizations generate immense volumes of data, but an estimated 95% of this data goes unused – largely because it is fragmented, inaccessible, and unstructured.... Details

In partnership with Reuters, Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea... Details